UK begins AstraZeneca Covid-19 vaccine rollout with dialysis patient

The UK's National Health Service (NHS) on Monday began rolling out the Oxford University vaccine developed by AstraZeneca as protection against Covid-19

First Astrazeneca vaccine beneficiary
82-year-old Brian Pinker receives the Oxford University/AstraZeneca Covid-19 vaccine from nurse Sam Foster at the Churchill Hospital in Oxford, England, Monday, Jan. 4, 2021. (Steve Parsons/Pool Photo via AP)
Press Trust of India London
1 min read Last Updated : Jan 04 2021 | 2:29 PM IST

The UK's National Health Service (NHS) on Monday began rolling out the Oxford University vaccine developed by AstraZeneca as protection against COVID-19, with an 82-year-old Oxford-born dialysis patient becoming the first to receive the new jab.

Brian Pinker is among the first to be vaccinated by the Oxford University Hospital's (OUH) chief nurse, hailed as a major milestone in the phased vaccination programme being undertaken by the NHS as the Oxford jab became the second vaccine approved for rollout after the Pfizer/BioNTech vaccine.

A retired maintenance manager who has been having dialysis for kidney disease at the hospital for a number of years, Pinker said he was pleased to be getting protection against the virus, giving him peace of mind as he continues to receive treatment.

"I am so pleased to be getting the COVID-19 vaccine today and really proud that it is one that was invented in Oxford. The nurses, doctors and staff today have all been brilliant and I can now really look forward to celebrating my 48th wedding anniversary with my wife Shirley later this year, he said.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :AstraZenecaCoronavirus VaccineUK

First Published: Jan 04 2021 | 2:09 PM IST

Next Story